Correction to: Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - New data and literature review(Orphanet Journal of Rare Diseases (2018) 13:47 DOI: 10.1186/s13023-018-0795-5)

James F.H. Pittaway, Christopher Harrison, Yumie Rhee, Muriel Holder-Espinasse, Alan E. Fryer, Tim Cundy, William M. Drake, Melita D. Irving

Research output: Contribution to journalComment/debate

Abstract

After publication of this article [1], it is noticed reference no. 17 was incorrectly provided, details are shown below: Original reference no. 17: Canalis E, Schilling L, Yee SP, Lee SK, Zanotti S. Hajdu Cheney mouse mutants exhibit osteopenia, increased Osteoclastogenesis, and bone resorption. J Biol Chem. 2016;291(4):1538-51. https://doi.org/10.1074/jbc.M115.685453.Correct reference no. 17: G. Adami, M. Rossini, D. Gatti, G. Orsolini, L. Idolazzi, O. Viapiana, A. Scarpa, E. Canalis Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab Bone, 92 (2016), pp. 150-156. The author apologizes for the inconvenience caused..

Original languageEnglish
Article number104
JournalOrphanet Journal of Rare Diseases
Volume14
Issue number1
DOIs
Publication statusPublished - 2019 May 10

All Science Journal Classification (ASJC) codes

  • Genetics(clinical)
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Correction to: Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - New data and literature review(Orphanet Journal of Rare Diseases (2018) 13:47 DOI: 10.1186/s13023-018-0795-5)'. Together they form a unique fingerprint.

  • Cite this